Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Biotech Business October 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Combination Antibody Therapy
... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$215.4 Billion ... Read More
-
Genomics
... of 19.0% over the analysis period 2023-2030. Sequencing Technology, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. ... Read More
-
PEGylated Proteins
... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Synthetic DNA
... at a CAGR of 18.6% over the analysis period 2023-2030. Pharmaceuticals & Diagnostics Application, one of the segments analyzed in the report, is expected to record a 20.0% CAGR and reach US$4.5 Billion by the ... Read More
-
In Vitro Lung Model
... reach US$2.0 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2023-2030. 2D In Vitro Lung Model, one of the segments analyzed in the report, is expected to record a 16.5% ... Read More
-
Peptide Synthesis
... at a CAGR of 4.3% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Chiral Chromatography Column
... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Pharmaceutical & Biotechnology End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$54.2 ... Read More
-
Competent Cells
... at a CAGR of 7.9% over the analysis period 2023-2030. Cloning Application, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Genome Editing / Genome Engineering
... is expected to reach US$37.2 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. Genetic Engineering Application, one of the segments analyzed in the report, is expected to record a ... Read More
-
Human Liver Models
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$225.8 Million ... Read More
-
Human Platelet Lysate
... by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Clinical Use Application, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$77.7 Million ... Read More
-
Oligonucleotide Synthesis
... at a CAGR of 15.7% over the analysis period 2023-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$8.6 Billion by the end of ... Read More
-
Animal Blood Plasma Products and Derivatives
... the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Cell Culture Media Application, one of the segments analyzed in the report, is ... Read More
-
Stem Cell Services
... by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market ... Read More
-
Threat Detection Systems
... by 2030, growing at a CAGR of 12.8% over the analysis period 2023-2030. Explosive Detection, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$244.7 Billion by ... Read More
-
Systemic Radiotherapy
... at a CAGR of 3.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of ... Read More
-
Breakthrough Therapy (BT) Designation
... reach US$415.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach ... Read More
-
Worldwide Biotech October 2024
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Global Lysozyme Market Research Report 2024
... anticipated to reach to 3.74%. Asia, Latin America and Europe are the key consumption regions of lysozyme, especially in such countries like China, Mexico, Brazil, etc. In 2023, Asia Pacific consumed 42.34% lysozyme globally while ... Read More
-
Chiral Chemicals
... CAGR of 6.3% over the analysis period 2023-2030. Traditional Separation Method, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$50.8 Billion by the end of the ... Read More
-
United States Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032
... Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032 United States Next Generation Sequencing Market Size ... Read More
-
Custom Antibody
... CAGR of 9.0% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$320.3 Million by the end of the analysis ... Read More
-
DNA and Gene Chip
... 2030, growing at a CAGR of 10.2% over the analysis period 2023-2030. DNA and Gene Chip Consumables, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$12.6 ... Read More
-
High-Performance Liquid Chromatography (HPLC)
... 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.2 Billion by the ... Read More
Research Assistance
